Literature DB >> 20816706

In vitro and in vivo model systems to study microbial biofilm formation.

Tom Coenye1, Hans J Nelis.   

Abstract

Biofilm formation is often considered the underlying reason why treatment with an antimicrobial agent fails and as an estimated 65-80% of all human infections is thought to be biofilm-related, this presents a serious challenge. Biofilm model systems are essential to gain a better understanding of the mechanisms involved in biofilm formation and resistance. In this review a comprehensive overview of various in vitro and in vivo systems is presented, and their advantages and disadvantages are discussed.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20816706     DOI: 10.1016/j.mimet.2010.08.018

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  101 in total

1.  Biofilm Formation by Avian Pathogenic Escherichia coli is Not Related to In Vivo Pathogenicity.

Authors:  Suelle V Rodrigues; Vanessa Laviniki; Karen A Borges; Thales Q Furian; Hamilton L S Moraes; Vladimir P Nascimento; Carlos T P Salle
Journal:  Curr Microbiol       Date:  2018-12-04       Impact factor: 2.188

Review 2.  Pleiotropic signaling pathways orchestrate yeast development.

Authors:  Joshua A Granek; Ömür Kayıkçı; Paul M Magwene
Journal:  Curr Opin Microbiol       Date:  2011-09-28       Impact factor: 7.934

3.  A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.

Authors:  Yan Q Xiong; Angeles Estellés; L Li; W Abdelhady; R Gonzales; Arnold S Bayer; Edgar Tenorio; Anton Leighton; Stefan Ryser; Lawrence M Kauvar
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

4.  Quantitative and Qualitative Assessment Methods for Biofilm Growth: A Mini-review.

Authors:  Christina Wilson; Rachel Lukowicz; Stefan Merchant; Helena Valquier-Flynn; Jeniffer Caballero; Jasmin Sandoval; Macduff Okuom; Christopher Huber; Tessa Durham Brooks; Erin Wilson; Barbara Clement; Christopher D Wentworth; Andrea E Holmes
Journal:  Res Rev J Eng Technol       Date:  2017-10-24

5.  In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin.

Authors:  Ebru Evren; Erkan Yurtcu
Journal:  Folia Microbiol (Praha)       Date:  2015-05-04       Impact factor: 2.099

Review 6.  Chronic Wound Biofilm Model.

Authors:  Kasturi Ganesh; Mithun Sinha; Shomita S Mathew-Steiner; Amitava Das; Sashwati Roy; Chandan K Sen
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-07-01       Impact factor: 4.730

7.  Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies.

Authors:  Yucheng Wang; Ximing Wu; Jia Chen; Rehab Amin; Min Lu; Brijesh Bhayana; Jie Zhao; Clinton K Murray; Michael R Hamblin; David C Hooper; Tianhong Dai
Journal:  J Infect Dis       Date:  2016-02-17       Impact factor: 5.226

8.  Use of a high-throughput in vitro microfluidic system to develop oral multi-species biofilms.

Authors:  Derek S Samarian; Nicholas S Jakubovics; Ting L Luo; Alexander H Rickard
Journal:  J Vis Exp       Date:  2014-12-01       Impact factor: 1.355

9.  Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.

Authors:  Jessica Amber Jennings; Daniel P Carpenter; Karen S Troxel; Karen E Beenken; Mark S Smeltzer; Harry S Courtney; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2015-07       Impact factor: 4.176

10.  A mucosal model to study microbial biofilm development and anti-biofilm therapeutics.

Authors:  Michele J Anderson; Patrick J Parks; Marnie L Peterson
Journal:  J Microbiol Methods       Date:  2012-12-14       Impact factor: 2.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.